<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03129672</url>
  </required_header>
  <id_info>
    <org_study_id>000001</org_study_id>
    <nct_id>NCT03129672</nct_id>
  </id_info>
  <brief_title>Distal Tibia Sarcoma Treatment Using Allograft Arthrodesis of the Ankle</brief_title>
  <official_title>Distal Tibia Sarcoma Treatment Using Allograft Arthrodesis of the Ankle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Patricia Bonilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital del Niño &quot;Dr. José Renán Esquivel&quot;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital del Niño &quot;Dr. José Renán Esquivel&quot;</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study show the clinical results of limb salvage for primary malignant bone tumor of the
      distal tibia using block excision of the tumor and reconstruction with allograft arthrodesis
      with different methods of fixation (plates or intramedullary nail system)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is well known that before the 1980`s the usual treatment for the sarcomas of the distal
      tibia was amputation (1). Currently, however, after the improvement of the chemotherapy
      treatments, potential reconstructions of the area in well studied patients are possible, and
      for that we have a wide range: auto graft, allograft and prosthetic reconstructions (2, 3)

      Is important to know that osteosarcoma still meant the principal diagnosis, followed by the
      Ewing sarcoma and synovial sarcoma, but their malignant potency is lower than when they are
      present in the rest of the body (4, 5, and 6)

      The purpose of this study is to recollect the patients' data followed from different
      institutions and countries that have the criteria for their inclusion in the study (primary
      malignant bone tumor of the distal tibia that underwent block excision of the tumor and
      reconstruction with allograft arthrodesis from the patient management for any of the
      multidisciplinary sarcoma team including in this study).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 20, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>principal diagnosis of the patients that wen trough ankle after resection of a primary malignant tumor of the distal tibia</measure>
    <time_frame>1 month</time_frame>
    <description>osteosarcoma: 5 patientas (2 females of 18 and 15 years old and 3 males of 19, 24 and 16 years old) telangiectasic osteosarcoma (1 female of 21 years old) Ewing sarcoma (1 male of 33 years old)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mobility</measure>
    <time_frame>5 month to 10 years follow up</time_frame>
    <description>surgical site infection, non union, malunion, osteosynthesis material failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>5 months to 10 years follow up</time_frame>
    <description>secundary of the primary tumor diagnosis or metastatic disease of it</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MSTS SCORE</measure>
    <time_frame>5 month to 10 years follow up</time_frame>
    <description>total points score of the msts score at the final follow up</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Bone Neoplasm</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>allograft arthrodesis of ankle</intervention_name>
    <description>patients that underwent trought a block resection of a malignant tumor of the distal tibia and reconstruction with allograft arthrodesis</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patients that were diagnosis with primary malignant bone tumor of the distal tibia and
        went trough resection and reconstruction with allograft
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - all patients with histopathologyc diagnosis of a primary malignant bone tumor at the
        distal tibia that went through a tumor resection and received reconstruction with allograft
        as first surgical treatment

        Exclusion Criteria:

          -  none histopatologic proved diagnosis

          -  patients that received other kind of surgical treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>patricia bonilla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital del Niño</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>patricia bonilla, MD</last_name>
    <phone>+507-5129813</phone>
    <phone_ext>150</phone_ext>
    <email>patibh_8@hotmail.com, patriciabonillah@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jorge Navia, MD</last_name>
    <phone>+57-3155643400</phone>
    <email>jorgenaviagiraldo@gmail.com, oncologiaortopedica@emcali.net.co</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Panama Children Hospital</name>
      <address>
        <city>Panama</city>
        <zip>0823</zip>
        <country>Panama</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>patricia bonilla, MD</last_name>
      <phone>+507-5129813</phone>
      <phone_ext>150</phone_ext>
      <email>patibh_8@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jorge Navia, MD</last_name>
      <phone>+57-3155643400</phone>
      <email>jorgenaviagiraldo@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Panama</country>
  </location_countries>
  <reference>
    <citation>Burrows HJ, Wilson JN, Scales JT. Excision of tumours of humerus and femur, with restoration by internal prostheses. J Bone Joint Surg Br. 1975 May;57(2):148-59.</citation>
    <PMID>1141281</PMID>
  </reference>
  <reference>
    <citation>Ebeid W, Amin S, Abdelmegid A, Refaat Y, Ghoneimy A. Reconstruction of distal tibial defects following resection of malignant tumours by pedicled vascularised fibular grafts. Acta Orthop Belg. 2007 Jun;73(3):354-9.</citation>
    <PMID>17715726</PMID>
  </reference>
  <reference>
    <citation>Liu T, Guo X, Zhang X, Li Z, Zhang Q. Reconstruction with pasteurized autograft for primary malignant bone tumor of distal tibia. Bull Cancer. 2012 Sep;99(9):87-91. doi: 10.1684/bdc.2012.1626.</citation>
    <PMID>22863837</PMID>
  </reference>
  <reference>
    <citation>Ruggieri P, Angelini A, Jorge FD, Maraldi M, Giannini S. Review of foot tumors seen in a university tumor institute. J Foot Ankle Surg. 2014 May-Jun;53(3):282-5. doi: 10.1053/j.jfas.2014.01.015. Review.</citation>
    <PMID>24751209</PMID>
  </reference>
  <reference>
    <citation>Azevedo CP, Casanova JM, Guerra MG, Santos AL, Portela MI, Tavares PF. Tumors of the foot and ankle: a single-institution experience. J Foot Ankle Surg. 2013 Mar-Apr;52(2):147-52. doi: 10.1053/j.jfas.2012.12.004. Epub 2013 Jan 16.</citation>
    <PMID>23333280</PMID>
  </reference>
  <reference>
    <citation>Zeytoonjian T, Mankin HJ, Gebhardt MC, Hornicek FJ. Distal lower extremity sarcomas: frequency of occurrence and patient survival rate. Foot Ankle Int. 2004 May;25(5):325-30.</citation>
    <PMID>15134614</PMID>
  </reference>
  <reference>
    <citation>Clayer M, Doyle S, Sangha N, Grimer R. The toronto extremity salvage score in unoperated controls: an age, gender, and country comparison. Sarcoma. 2012;2012:717213. doi: 10.1155/2012/717213. Epub 2012 Sep 13.</citation>
    <PMID>23028240</PMID>
  </reference>
  <reference>
    <citation>Ozger H, Eralp L, Türker M, Basaran M. Surgical treatment of malignant tumors of the foot and ankle. Int J Clin Oncol. 2005 Apr;10(2):127-32.</citation>
    <PMID>15864699</PMID>
  </reference>
  <reference>
    <citation>Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993 Jan;(286):241-6.</citation>
    <PMID>8425352</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2015</study_first_submitted>
  <study_first_submitted_qc>April 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2017</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital del Niño &quot;Dr. José Renán Esquivel&quot;</investigator_affiliation>
    <investigator_full_name>Patricia Bonilla</investigator_full_name>
    <investigator_title>Orthopedic Oncologist MD</investigator_title>
  </responsible_party>
  <keyword>allograft</keyword>
  <keyword>distal tibia sarcoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
    <mesh_term>Bone Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

